| Literature DB >> 26048793 |
Benjamin P Fauber1, Alberto Gobbi2, Kirk Robarge2, Aihe Zhou2, Adrian Barnard3, Jianhua Cao4, Yuzhong Deng2, Céline Eidenschenk2, Christine Everett2, Arunima Ganguli3, Julie Hawkins3, Adam R Johnson2, Hank La2, Maxine Norman3, Gary Salmon3, Susan Summerhill3, Wenjun Ouyang2, Wei Tang4, Harvey Wong2.
Abstract
The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, RORc, or NR1F3) is a promising target for the treatment of autoimmune diseases. RORc is a critical regulator in the production of the pro-inflammatory cytokine interleukin-17. We discovered a series of potent and selective imidazo[1,5-a]pyridine and -pyrimidine RORc inverse agonists. The most potent compounds displayed >300-fold selectivity for RORc over the other ROR family members, PPARγ, and NRs in our cellular selectivity panel. The favorable potency, selectivity, and physiochemical properties of GNE-0946 (9) and GNE-6468 (28), in addition to their potent suppression of IL-17 production in human primary cells, support their use as chemical biology tools to further explore the role of RORc in human biology.Entities:
Keywords: GNE-0946; GNE-6468; IL-17; PPARγ; RORc; RORγ
Mesh:
Substances:
Year: 2015 PMID: 26048793 DOI: 10.1016/j.bmcl.2015.05.055
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823